Logo image of MTUS

METALLUS INC (MTUS) Stock Fundamental Analysis

NYSE:MTUS - New York Stock Exchange, Inc. - US8873991033 - Common Stock - Currency: USD

15.94  -0.46 (-2.8%)

After market: 15.94 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MTUS. MTUS was compared to 156 industry peers in the Metals & Mining industry. While MTUS seems to be doing ok healthwise, there are quite some concerns on its profitability. MTUS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MTUS had positive earnings in the past year.
In the past year MTUS has reported a negative cash flow from operations.
Of the past 5 years MTUS 4 years were profitable.
Each year in the past 5 years MTUS had a positive operating cash flow.
MTUS Yearly Net Income VS EBIT VS OCF VS FCFMTUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

MTUS's Return On Assets of -1.94% is in line compared to the rest of the industry. MTUS outperforms 50.64% of its industry peers.
MTUS has a Return On Equity of -3.12%. This is comparable to the rest of the industry: MTUS outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -1.94%
ROE -3.12%
ROIC N/A
ROA(3y)4.01%
ROA(5y)4.11%
ROE(3y)6.39%
ROE(5y)6.54%
ROIC(3y)N/A
ROIC(5y)N/A
MTUS Yearly ROA, ROE, ROICMTUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

MTUS's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of MTUS has declined.
The Gross Margin of MTUS (6.62%) is worse than 60.90% of its industry peers.
In the last couple of years the Gross Margin of MTUS has declined.
MTUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.62%
OM growth 3Y-56.4%
OM growth 5YN/A
PM growth 3Y-79.2%
PM growth 5YN/A
GM growth 3Y-19.3%
GM growth 5YN/A
MTUS Yearly Profit, Operating, Gross MarginsMTUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 -5 10 15

4

2. Health

2.1 Basic Checks

MTUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MTUS has less shares outstanding than it did 1 year ago.
MTUS has a better debt/assets ratio than last year.
MTUS Yearly Shares OutstandingMTUS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
MTUS Yearly Total Debt VS Total AssetsMTUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MTUS has an Altman-Z score of 2.13. This is not the best score and indicates that MTUS is in the grey zone with still only limited risk for bankruptcy at the moment.
MTUS has a Altman-Z score of 2.13. This is comparable to the rest of the industry: MTUS outperforms 41.67% of its industry peers.
MTUS has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
MTUS's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. MTUS outperforms 74.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.13
ROIC/WACCN/A
WACC10.07%
MTUS Yearly LT Debt VS Equity VS FCFMTUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MTUS has a Current Ratio of 2.03. This indicates that MTUS is financially healthy and has no problem in meeting its short term obligations.
MTUS has a Current ratio (2.03) which is comparable to the rest of the industry.
A Quick Ratio of 1.21 indicates that MTUS should not have too much problems paying its short term obligations.
MTUS has a worse Quick ratio (1.21) than 60.26% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.21
MTUS Yearly Current Assets VS Current LiabilitesMTUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

MTUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.71%.
The earnings per share for MTUS have been decreasing by -44.91% on average. This is quite bad
MTUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.43%.
MTUS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.46% yearly.
EPS 1Y (TTM)-93.71%
EPS 3Y-44.91%
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-20.43%
Revenue growth 3Y-5.46%
Revenue growth 5YN/A
Sales Q2Q%3.36%

3.2 Future

Based on estimates for the next years, MTUS will show a very strong growth in Earnings Per Share. The EPS will grow by 54.68% on average per year.
Based on estimates for the next years, MTUS will show a quite strong growth in Revenue. The Revenue will grow by 8.82% on average per year.
EPS Next Y29.07%
EPS Next 2Y54.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.68%
Revenue Next 2Y8.82%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MTUS Yearly Revenue VS EstimatesMTUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
MTUS Yearly EPS VS EstimatesMTUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 159.40, which means the current valuation is very expensive for MTUS.
The rest of the industry has a similar Price/Earnings ratio as MTUS.
MTUS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.93.
The Price/Forward Earnings ratio is 12.34, which indicates a correct valuation of MTUS.
MTUS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MTUS is cheaper than 72.44% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MTUS to the average of the S&P500 Index (35.31), we can say MTUS is valued rather cheaply.
Industry RankSector Rank
PE 159.4
Fwd PE 12.34
MTUS Price Earnings VS Forward Price EarningsMTUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

60.26% of the companies in the same industry are more expensive than MTUS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.33
MTUS Per share dataMTUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MTUS's earnings are expected to grow with 54.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.48
PEG (5Y)N/A
EPS Next 2Y54.68%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MTUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

METALLUS INC

NYSE:MTUS (8/14/2025, 8:04:01 PM)

After market: 15.94 0 (0%)

15.94

-0.46 (-2.8%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners86.85%
Inst Owner ChangeN/A
Ins Owners3.9%
Ins Owner Change4.71%
Market Cap669.80M
Analysts82.5
Price Target22.44 (40.78%)
Short Float %5.69%
Short Ratio5.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1249.83%
Min EPS beat(2)-2455.3%
Max EPS beat(2)-44.35%
EPS beat(4)0
Avg EPS beat(4)-682.68%
Min EPS beat(4)-2455.3%
Max EPS beat(4)-44.35%
EPS beat(8)3
Avg EPS beat(8)-331.48%
EPS beat(12)4
Avg EPS beat(12)-219.89%
EPS beat(16)8
Avg EPS beat(16)-155.64%
Revenue beat(2)1
Avg Revenue beat(2)0.87%
Min Revenue beat(2)-2.41%
Max Revenue beat(2)4.16%
Revenue beat(4)1
Avg Revenue beat(4)-7.99%
Min Revenue beat(4)-25.39%
Max Revenue beat(4)4.16%
Revenue beat(8)1
Avg Revenue beat(8)-4.95%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10%
PT rev (3m)10%
EPS NQ rev (1m)-6.25%
EPS NQ rev (3m)-11.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.23%
Revenue NQ rev (1m)-0.57%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 159.4
Fwd PE 12.34
P/S 0.64
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA 14.33
EPS(TTM)0.1
EY0.63%
EPS(NY)1.29
Fwd EY8.11%
FCF(TTM)-2.53
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS24.82
BVpS16.33
TBVpS16.25
PEG (NY)5.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -3.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.62%
FCFM N/A
ROA(3y)4.01%
ROA(5y)4.11%
ROE(3y)6.39%
ROE(5y)6.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-56.4%
OM growth 5YN/A
PM growth 3Y-79.2%
PM growth 5YN/A
GM growth 3Y-19.3%
GM growth 5YN/A
F-Score2
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.15
Cap/Depr 136.76%
Cap/Sales 7.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.21
Altman-Z 2.13
F-Score2
WACC10.07%
ROIC/WACCN/A
Cap/Depr(3y)85.34%
Cap/Depr(5y)59.9%
Cap/Sales(3y)3.92%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.71%
EPS 3Y-44.91%
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y29.07%
EPS Next 2Y54.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.43%
Revenue growth 3Y-5.46%
Revenue growth 5YN/A
Sales Q2Q%3.36%
Revenue Next Year6.68%
Revenue Next 2Y8.82%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-117.34%
EBIT growth 3Y-58.78%
EBIT growth 5YN/A
EBIT Next Year239.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.84%
OCF growth 3Y-41.07%
OCF growth 5YN/A